These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 22105474

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B.
    Cancer; 2008 Jul 15; 113(2):256-65. PubMed ID: 18506737
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms].
    Zhu XZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan 15; 16(1):12-4. PubMed ID: 23691561
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K.
    Curr Opin Oncol; 2012 Jul 15; 24(4):433-40. PubMed ID: 22510940
    [Abstract] [Full Text] [Related]

  • 6. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
    Rindi G, Capella C, Solcia E.
    Q J Nucl Med; 2000 Mar 15; 44(1):13-21. PubMed ID: 10932598
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR, Ghorra C, Rassy M, Kesserouani C, Kattan J.
    Asian Pac J Cancer Prev; 2016 Mar 15; 17(5):2679-81. PubMed ID: 27268650
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Pathology of neuroendocrine neoplasms].
    Anlauf M, Gerlach P, Schott M, Raffel A, Krausch M, Knoefel WT, Pavel M, Klöppel G.
    Chirurg; 2011 Jul 15; 82(7):567-73. PubMed ID: 21487814
    [Abstract] [Full Text] [Related]

  • 15. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
    Martin JA, Warner RR, Wisnivesky JP, Kim MK.
    Eur J Cancer; 2017 May 15; 76():197-204. PubMed ID: 28334622
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E, Dursun N, Ozyalvacli G, Hacihasanoglu E, Behzatoglu K, Calay O.
    Ann Diagn Pathol; 2015 Apr 15; 19(2):81-7. PubMed ID: 25702616
    [Abstract] [Full Text] [Related]

  • 18. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
    Federspiel BH, Hansen CP, Vainer B, Hasselby JP, Bardram L, Knigge U.
    Ugeskr Laeger; 2010 Oct 25; 172(43):2946-50. PubMed ID: 21040672
    [Abstract] [Full Text] [Related]

  • 19. [Diagnostic criteria and classification of gastro-intestinal pancreatic endocrine tumors].
    Capella C, Uccella S, Albarello L, Feltri M, La Rosa S.
    Minerva Endocrinol; 2001 Sep 25; 26(3):103-10. PubMed ID: 11753231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.